glp-1/gip agonist The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Schematic illustration of monoagonists, dual
Description
Visualization: JS

Experiments in primary islets reveal -arrestin1 limits the insulin response to GLP-1, but not GIP or tirzepatide, suggesting that the biased agonism of tirzepatide enhances insulin secretion
16 Based on this pharmacology setmelanotide is prescribed alongside diet and exercise to facilitate weight loss and enhance quality of life in patients with genetic disorders of obesity

For insurance purposes, this matters because coverage typically requires the medication to match your diagnosis

Azzam AY, Essibayi MA, Farkas N et al (2024) Efficacy of Tirzepatide dual GIP/GLP-1 receptor agonist in patients with idiopathic intracranial hypertension
